Rationale: Although it is clear that cystic fibrosis (CF) airway disease begins at a very young age, the early and subsequent steps in disease pathogenesis and the relative contribution of infection, mucus, and inflammation are not well understood. Objectives: As one approach to assessing the early contribution of infection, we tested the hypothesis that early and continuous antibiotics would decrease the airway bacterial burden. We believed that, if they do, this might reveal aspects of the disease that are more or less sensitive to decreasing infection. Methods: Three groups of pigs were studied from birth until ∼3 weeks of age: 1) wild-type, 2) CF, and 3) CF pigs treated continuously with broad-spectrum antibiotics from birth until study completion. Disease was assessed with chest computed tomography, histopathology, microbiology, and BAL. Measurements and Main Results: Disease was present by 3 weeks of age in CF pigs. Continuous antibiotics from birth improved chest computed tomography imaging abnormalities and airway mucus accumulation but not airway inflammation in the CF pig model. However, reducing bacterial infection did not improve two disease features already present at birth in CF pigs: air trapping and submucosal gland duct plugging. In the CF sinuses, antibiotics did not prevent the development of infection or disease or the number of bacteria but did alter the bacterial species. Conclusions: These findings suggest that CF airway disease begins immediately after birth and that early and continuous antibiotics impact some, but not all, aspects of CF lung disease development.
Rationale: Although it is clear that cystic fibrosis (CF) airway disease begins at a very young age, the early and subsequent steps in disease pathogenesis and the relative contribution of infection, mucus, and inflammation are not well understood. Objectives: As one approach to assessing the early contribution of infection, we tested the hypothesis that early and continuous antibiotics would decrease the airway bacterial burden. We believed that, if they do, this might reveal aspects of the disease that are more or less sensitive to decreasing infection. Methods: Three groups of pigs were studied from birth until ∼3 weeks of age: 1) wild-type, 2) CF, and 3) CF pigs treated continuously with broad-spectrum antibiotics from birth until study completion. Disease was assessed with chest computed tomography, histopathology, microbiology, and BAL. Measurements and Main Results: Disease was present by 3 weeks of age in CF pigs. Continuous antibiotics from birth improved chest computed tomography imaging abnormalities and airway mucus accumulation but not airway inflammation in the CF pig model. However, reducing bacterial infection did not improve two disease features already present at birth in CF pigs: air trapping and submucosal gland duct plugging. In the CF sinuses, antibiotics did not prevent the development of infection or disease or the number of bacteria but did alter the bacterial species. Conclusions: These findings suggest that CF airway disease begins immediately after birth and that early and continuous antibiotics impact some, but not all, aspects of CF lung disease development.
Authors: Anna Ermund; Lauren N Meiss; Brendan Dolan; Andrea Bähr; Nikolai Klymiuk; Gunnar C Hansson Journal: Eur Respir J Date: 2018-08-30 Impact factor: 16.671
Authors: Xingshen Sun; Alicia K Olivier; Yaling Yi; Christopher E Pope; Hillary S Hayden; Bo Liang; Hongshu Sui; Weihong Zhou; Kyle R Hager; Yulong Zhang; Xiaoming Liu; Ziying Yan; John T Fisher; Nicholas W Keiser; Yi Song; Scott R Tyler; J Adam Goeken; Joann M Kinyon; Matthew C Radey; Danielle Fligg; Xiaoyan Wang; Weiliang Xie; Thomas J Lynch; Paul M Kaminsky; Mitchell J Brittnacher; Samuel I Miller; Kalpaj Parekh; David K Meyerholz; Lucas R Hoffman; Timothy Frana; Zoe A Stewart; John F Engelhardt Journal: Am J Pathol Date: 2014-03-15 Impact factor: 4.307
Authors: Charles R Esther; Marianne S Muhlebach; Camille Ehre; David B Hill; Matthew C Wolfgang; Mehmet Kesimer; Kathryn A Ramsey; Matthew R Markovetz; Ian C Garbarine; M Gregory Forest; Ian Seim; Bryan Zorn; Cameron B Morrison; Martial F Delion; William R Thelin; Diane Villalon; Juan R Sabater; Lidija Turkovic; Sarath Ranganathan; Stephen M Stick; Richard C Boucher Journal: Sci Transl Med Date: 2019-04-03 Impact factor: 17.956
Authors: Katherine B Frayman; Kristine M Wylie; David S Armstrong; Rosemary Carzino; Stephanie D Davis; Thomas W Ferkol; Keith Grimwood; Gregory A Storch; Sarath C Ranganathan Journal: J Cyst Fibros Date: 2018-12-21 Impact factor: 5.482
Authors: Kathryn A Ramsey; Tim Rosenow; Lidija Turkovic; Billy Skoric; Georgia Banton; Anne-Marie Adams; Shannon J Simpson; Conor Murray; Sarath C Ranganathan; Stephen M Stick; Graham L Hall Journal: Am J Respir Crit Care Med Date: 2016-01-01 Impact factor: 21.405
Authors: Alan S Brody; Jeffrey S Klein; Paul L Molina; Joanne Quan; Judy A Bean; Robert W Wilmott Journal: J Pediatr Date: 2004-07 Impact factor: 4.406
Authors: Bradley H Rosen; T Idil Apak Evans; Shashanna R Moll; Jaimie S Gray; Bo Liang; Xingshen Sun; Yulong Zhang; Chandler W Jensen-Cody; Anthony M Swatek; Weihong Zhou; Nan He; Pavana G Rotti; Scott R Tyler; Nicholas W Keiser; Preston J Anderson; Leonard Brooks; Yalan Li; R Marshall Pope; Maheen Rajput; Eric A Hoffman; Kai Wang; J Kirk Harris; Kalpaj R Parekh; Katherine N Gibson-Corley; John F Engelhardt Journal: Am J Respir Crit Care Med Date: 2018-05-15 Impact factor: 30.528
Authors: Gwyneth Davies; Lena P Thia; Janet Stocks; Andrew Bush; Ah-Fong Hoo; Angie Wade; The Thanh Diem Nguyen; Alan S Brody; Alistair Calder; Nigel J Klein; Siobhán B Carr; Colin Wallis; Ranjan Suri; Caroline S Pao; Gary Ruiz; Ian M Balfour-Lynn Journal: J Cyst Fibros Date: 2020-02-07 Impact factor: 5.482
Authors: Jamison J Ash; Brieanna M Hilkin; Nicholas D Gansemer; Eric A Hoffman; Joseph Zabner; David A Stoltz; Mahmoud H Abou Alaiwa Journal: Physiol Rep Date: 2022-09